=== PAGE 6 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Nikki Hill, PharmD
AbbVie, Inc.
NDA 211765/MA 934

Questions related to the submission of your response letter should be emailed to the OPDP
RPM at CDER-OPDP-RPM@fda.hhs.gov.

Sincerely,

{See appended electronic signature page}

Lindsay McCann, PharmD, BCCCP
Regulatory Review Officer
Division of Advertising & Promotion Review 1
Office of Prescription Drug Promotion

{See appended electronic signature page}

Susannah O'Donnell, MPH, RAC
Team Leader
Division of Advertising & Promotion Review 1
Office of Prescription Drug Promotion

Page 6

Reference ID: 5438418
